Showing 1 - 2 results of 2 for search 'Michael Schuepbach', query time: 0.02s Refine Results
  1. 1
    Biomarkers of neuropsychiatric symptoms in the Subthalamic Nucleus in Parkinson’s disease to inform closed-loop DBS

    Biomarkers of neuropsychiatric symptoms in the Subthalamic Nucleus in Parkinson’s disease to inform closed-loop DBS by Elena Bernasconi, Deborah Amstutz, Alberto Averna, Petra Fischer, Mario Sousa, Ines Debove, Katrin Petermann, Laura Alva, Andreia D. Magalhães, M. Lenard Lachenmayer, Thuy-Anh Nguyen, Michael Schuepbach, Andreas Nowacki, Claudio Pollo, Paul Krack, Gerd Tinkhauser

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).

    Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial). by Stefan Halbherr, Stefanie Lerch, Sebastian Bellwald, Petra Polakova, Bettina Bannert, Marie Roumet, Roch-Philippe Charles, Martin A Walter, Corrado Bernasconi, Valérie Lisa Halbherr, Camille Peitsch, Pascal C Baumgartner, Céline Kaufmann, Vanessa Aires, Heinrich P Mattle, Alain Kaelin-Lang, Andreas Hartmann, Michael Schuepbach

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: